Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 30, 2020
ProBioGen announced the closing of a master service agreement with Asahi Kasei Pharma.
read more
Tuesday, December 01, 2020
Catalent announced the appointment of Behzad Mahdavi, Ph.D., MBA, as Vice President of Open Innovation, Biologics, Cell and Gene Therapy.
read more
Tuesday, December 01, 2020
Mustang Bio and Minaris have signed an agreement to enable technology transfer and GMP clinical manufacturing of Mustang’s MB-107 lentiviral gene therapy program for the treatment of XSCID in Europe.
read more
Wednesday, December 02, 2020
Bora Pharmaceuticals announced the CDMO has successfully completed the acquisition of GSK’s Mississauga, Ontario facility.
read more
Wednesday, December 02, 2020
Jay Feldman has joined Pharmaceutics International, Inc. (Pii) as the Head of Information Technology.
read more
Wednesday, December 02, 2020
Lonza has announced additional investments in its oral drug product development and manufacturing capabilities at its Tampa, Florida site.
read more
Wednesday, December 02, 2020
WuXi Advanced Therapies announced the completion of a facility expansion that will triple its advanced testing capacity at the company's Philadelphia Navy Yard campus.
read more
Thursday, December 03, 2020
Idifarma has announced a partnership with Stefano Console from Swiss life sciences consultancy Oriento.
read more
Friday, December 04, 2020
CureVac and Wacker Chemie have signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
read more
Monday, December 07, 2020
Abzena has announced upgrades to its chemistry GMP suites.
read more
Tuesday, December 08, 2020
Piramal Pharma Limited has announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of APIs.
read more
Wednesday, December 09, 2020
Stelis BioSource has started the next phase of its continued investment program after having already invested well over $100m into its facilities in Bangalore, India.
read more
Wednesday, December 09, 2020
Vectura has signed a global license and development agreement with Kinaset for VR588, a preclinical novel inhaled pan-JAK inhibitor for prevention and treatment of severe asthma.
read more
Thursday, December 10, 2020
Lonza has announced an investment to expand its particle engineering and drug product capabilities at its Oregon site.
read more
Thursday, December 10, 2020
Recipharm has announced an investment and capacity expansion at its facility in Israel.
read more